Compare $EW vs $GEHC | Chartloom

Compare

$EW vs $GEHC

Edwards Lifesciences Corp · GE Healthcare Technologies Inc

Edwards Lifesciences Corp

GEHC

GE Healthcare Technologies Inc

Compare $EW vs $GEHC

Comparing Edwards Lifesciences Corp and GE Healthcare Technologies Inc

EWEdwards Lifesciences Corp

GEHCGE Healthcare Technologies Inc

EWEdwards Lifesciences Corp

Market cap

$49.06B

P/E (TTM)

48.98x

Forward P/E (NTM)

26.35x

Forward P/S (NTM)

6.75x

Rev growth (TTM)

14.6%

YTD performance

-0.1%

52W performance

12.5%

FCF yield

2.9%

GEHCGE Healthcare Technologies Inc

Market cap

$29.69B

P/E (TTM)

15.04x

Forward P/E (NTM)

12.46x

Forward P/S (NTM)

1.31x

Rev growth (TTM)

6.5%

YTD performance

-20.6%

52W performance

-12.5%

FCF yield

5.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GEHC

Detailed metrics comparison

Edwards Lifesciences Corp

GEHC

GE Healthcare Technologies Inc

Market Cap

EW$49.06B

GEHC$29.69B

Enterprise Value

EW$46.76B

GEHC$37.76B

Price

EW$85.21

GEHC$65.74

P/E Ratio

EW48.98x

GEHC15.04x

P/S Ratio

EW7.53x

GEHC1.40x

EV/Sales

EW7.18x

GEHC1.78x

EV/EBITDA

EW22.50x

GEHC11.19x

P/B Ratio

EW4.62x

GEHC2.65x

P/FCF Ratio

EW34.22x

GEHC18.81x

EV/FCF

EW32.61x

GEHC23.92x

PEG Ratio

EW3.36x

GEHC2.18x

Forward P/E (NTM)

EW26.35x

GEHC12.46x

Forward P/S (NTM)

EW6.75x

GEHC1.31x

Revenue (TTM)

EW$6.51B

GEHC$21.27B

Revenue Growth (YoY)

EW14.6%

GEHC6.5%

Forward Rev Growth

EW9.5%

GEHC4.6%

Gross Margin (TTM)

EW77.8%

GEHC39.5%

Operating Margin (TTM)

EW18.2%

GEHC12.9%

EBITDA Margin (TTM)

EW30.8%

GEHC15.7%

Net Margin (TTM)

EW15.4%

GEHC9.3%

FCF Margin (TTM)

EW22.0%

GEHC7.4%

Net Income (TTM)

EW$1.00B

GEHC$1.99B

FCF (TTM)

EW$1.43B

GEHC$1.58B

EPS (TTM)

EW$1.74

GEHC$4.37

ROE (TTM)

EW9.7%

GEHC18.9%

ROA (TTM)

EW7.4%

GEHC5.4%

ROIC (TTM)

EW9.2%

GEHC9.6%

Cash

EW$2.91B

GEHC$2.08B

Debt

EW$599M

GEHC$10.15B

Net Cash/Debt

EW$2.31B

GEHC$-8.07B

Current Ratio (TTM)

EW4.52x

GEHC1.26x

Quick Ratio (TTM)

EW3.69x

GEHC0.93x

Debt/Equity (TTM)

EW0.06x

GEHC0.92x

Debt/Assets (TTM)

EW0.0%

GEHC0.0%

Interest Coverage (TTM)

EWN/A

GEHCN/A

Net Debt/EBITDA (TTM)

EW0.00x

GEHC0.00x

Beta

EW0.84

GEHC0.85

52W Performance

EW12.5%

GEHC-12.5%

YTD Performance

EW-0.1%

GEHC-20.6%

% from 52W High

EW-11.5%

GEHC-26.8%

% from 52W Low

EW17.9%

GEHC11.9%

Asset Turnover (TTM)

EW0.48x

GEHC0.58x

FCF Yield (TTM)

EW2.9%

GEHC5.3%

Earnings Yield (TTM)

EW2.0%

GEHC6.7%

Dividend Yield (TTM)

EWN/A

GEHC0.2%

Rule of 40

EW36.6

GEHC13.9

EV/GP/RG

EW0.76

GEHC0.71

Ticker research

View EW research View GEHC research

Metric	EW Edwards Lifesciences Corp	GEHC GE Healthcare Technologies Inc
Market & Valuation
Market Cap	$49.06B	$29.69B
Enterprise Value	$46.76B	$37.76B
Price	$85.21	$65.74
P/E Ratio	48.98x	15.04x
P/S Ratio	7.53x	1.40x
EV/Sales	7.18x	1.78x
EV/EBITDA	22.50x	11.19x
P/B Ratio	4.62x	2.65x
P/FCF Ratio	34.22x	18.81x
EV/FCF	32.61x	23.92x
PEG Ratio	3.36x	2.18x
Forward P/E (NTM)	26.35x	12.46x
Forward P/S (NTM)	6.75x	1.31x
Revenue & Growth
Revenue (TTM)	$6.51B	$21.27B
Revenue Growth (YoY)	14.6%	6.5%
Forward Rev Growth	9.5%	4.6%
Profitability
Gross Margin (TTM)	77.8%	39.5%
Operating Margin (TTM)	18.2%	12.9%
EBITDA Margin (TTM)	30.8%	15.7%
Net Margin (TTM)	15.4%	9.3%
FCF Margin (TTM)	22.0%	7.4%
Net Income (TTM)	$1.00B	$1.99B
FCF (TTM)	$1.43B	$1.58B
EPS (TTM)	$1.74	$4.37
ROE (TTM)	9.7%	18.9%
ROA (TTM)	7.4%	5.4%
ROIC (TTM)	9.2%	9.6%
Financial Health
Cash	$2.91B	$2.08B
Debt	$599M	$10.15B
Net Cash/Debt	$2.31B	$-8.07B
Current Ratio (TTM)	4.52x	1.26x
Quick Ratio (TTM)	3.69x	0.93x
Debt/Equity (TTM)	0.06x	0.92x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.84	0.85
52W Performance	12.5%	-12.5%
YTD Performance	-0.1%	-20.6%
% from 52W High	-11.5%	-26.8%
% from 52W Low	17.9%	11.9%
Efficiency & Yields
Asset Turnover (TTM)	0.48x	0.58x
FCF Yield (TTM)	2.9%	5.3%
Earnings Yield (TTM)	2.0%	6.7%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	36.6	13.9
EV/GP/RG	0.76	0.71
Ticker research	View EW research	View GEHC research

Valuation

P/E Ratio

GEHC

15.04x

48.98x

P/S Ratio

GEHC

1.40x

7.53x

EV/FCF

GEHC

23.92x

32.61x

Growth & revenue

Revenue Growth TTM

14.6%

GEHC

6.5%

Forward Revenue Growth

9.5%

GEHC

4.6%

Profitability & performance

Gross Margin

77.8%

GEHC

39.5%

ROE

GEHC

18.9%

9.7%

FCF Yield %

GEHC

5.3%

2.9%

52-Week Performance

12.5%

GEHC

-12.5%

Detailed metrics comparison

Edwards Lifesciences Corp

GEHC

GE Healthcare Technologies Inc

Market Cap

EW$49.06B

GEHC$29.69B

Enterprise Value

EW$46.76B

GEHC$37.76B

Price

EW$85.21

GEHC$65.74

P/E Ratio

EW48.98x

GEHC15.04x

P/S Ratio

EW7.53x

GEHC1.40x

EV/Sales

EW7.18x

GEHC1.78x

EV/EBITDA

EW22.50x

GEHC11.19x

P/B Ratio

EW4.62x

GEHC2.65x

P/FCF Ratio

EW34.22x

GEHC18.81x

EV/FCF

EW32.61x

GEHC23.92x

PEG Ratio

EW3.36x

GEHC2.18x

Forward P/E (NTM)

EW26.35x

GEHC12.46x

Forward P/S (NTM)

EW6.75x

GEHC1.31x

Revenue (TTM)

EW$6.51B

GEHC$21.27B

Revenue Growth (YoY)

EW14.6%

GEHC6.5%

Forward Rev Growth

EW9.5%

GEHC4.6%

Gross Margin (TTM)

EW77.8%

GEHC39.5%

Operating Margin (TTM)

EW18.2%

GEHC12.9%

EBITDA Margin (TTM)

EW30.8%

GEHC15.7%

Net Margin (TTM)

EW15.4%

GEHC9.3%

FCF Margin (TTM)

EW22.0%

GEHC7.4%

Net Income (TTM)

EW$1.00B

GEHC$1.99B

FCF (TTM)

EW$1.43B

GEHC$1.58B

EPS (TTM)

EW$1.74

GEHC$4.37

ROE (TTM)

EW9.7%

GEHC18.9%

ROA (TTM)

EW7.4%

GEHC5.4%

ROIC (TTM)

EW9.2%

GEHC9.6%

Cash

EW$2.91B

GEHC$2.08B

Debt

EW$599M

GEHC$10.15B

Net Cash/Debt

EW$2.31B

GEHC$-8.07B

Current Ratio (TTM)

EW4.52x

GEHC1.26x

Quick Ratio (TTM)

EW3.69x

GEHC0.93x

Debt/Equity (TTM)

EW0.06x

GEHC0.92x

Debt/Assets (TTM)

EW0.0%

GEHC0.0%

Interest Coverage (TTM)

EWN/A

GEHCN/A

Net Debt/EBITDA (TTM)

EW0.00x

GEHC0.00x

Beta

EW0.84

GEHC0.85

52W Performance

EW12.5%

GEHC-12.5%

YTD Performance

EW-0.1%

GEHC-20.6%

% from 52W High

EW-11.5%

GEHC-26.8%

% from 52W Low

EW17.9%

GEHC11.9%

Asset Turnover (TTM)

EW0.48x

GEHC0.58x

FCF Yield (TTM)

EW2.9%

GEHC5.3%

Earnings Yield (TTM)

EW2.0%

GEHC6.7%

Dividend Yield (TTM)

EWN/A

GEHC0.2%

Rule of 40

EW36.6

GEHC13.9

EV/GP/RG

EW0.76

GEHC0.71

Ticker research

View EW research View GEHC research

Metric	EW Edwards Lifesciences Corp	GEHC GE Healthcare Technologies Inc
Market & Valuation
Market Cap	$49.06B	$29.69B
Enterprise Value	$46.76B	$37.76B
Price	$85.21	$65.74
P/E Ratio	48.98x	15.04x
P/S Ratio	7.53x	1.40x
EV/Sales	7.18x	1.78x
EV/EBITDA	22.50x	11.19x
P/B Ratio	4.62x	2.65x
P/FCF Ratio	34.22x	18.81x
EV/FCF	32.61x	23.92x
PEG Ratio	3.36x	2.18x
Forward P/E (NTM)	26.35x	12.46x
Forward P/S (NTM)	6.75x	1.31x
Revenue & Growth
Revenue (TTM)	$6.51B	$21.27B
Revenue Growth (YoY)	14.6%	6.5%
Forward Rev Growth	9.5%	4.6%
Profitability
Gross Margin (TTM)	77.8%	39.5%
Operating Margin (TTM)	18.2%	12.9%
EBITDA Margin (TTM)	30.8%	15.7%
Net Margin (TTM)	15.4%	9.3%
FCF Margin (TTM)	22.0%	7.4%
Net Income (TTM)	$1.00B	$1.99B
FCF (TTM)	$1.43B	$1.58B
EPS (TTM)	$1.74	$4.37
ROE (TTM)	9.7%	18.9%
ROA (TTM)	7.4%	5.4%
ROIC (TTM)	9.2%	9.6%
Financial Health
Cash	$2.91B	$2.08B
Debt	$599M	$10.15B
Net Cash/Debt	$2.31B	$-8.07B
Current Ratio (TTM)	4.52x	1.26x
Quick Ratio (TTM)	3.69x	0.93x
Debt/Equity (TTM)	0.06x	0.92x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.84	0.85
52W Performance	12.5%	-12.5%
YTD Performance	-0.1%	-20.6%
% from 52W High	-11.5%	-26.8%
% from 52W Low	17.9%	11.9%
Efficiency & Yields
Asset Turnover (TTM)	0.48x	0.58x
FCF Yield (TTM)	2.9%	5.3%
Earnings Yield (TTM)	2.0%	6.7%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	36.6	13.9
EV/GP/RG	0.76	0.71
Ticker research	View EW research	View GEHC research